Atlas Trials

Integrated Genomics in Oncogene-driven NSCLC With Acquired Resistance

Clinical trial NCT07122882 · ENROLLING_BY_INVITATION

Trial details

NCT number
NCT07122882
Sponsor
Chang Gung Memorial Hospital
Status
ENROLLING_BY_INVITATION
Study type
OBSERVATIONAL
Oncogene-addicted Non Small Cell Lung CancerEGFR MutationALK Fusion-positive Solid or CNS TumorsROS1 Fusion PositiveRET Fusion PositiveERBB2 Mutation-Related TumorsNTRK1 Fusion PositiveNTRK2 Fusion PositiveNTRK3 Fusion PositiveNRG1 FusionBRAF V600 MutationKRAS G12C Mutation
Start date
2025-09-01
Primary completion
2027-05-11
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.